PUBLISHER: The Business Research Company | PRODUCT CODE: 1951651
PUBLISHER: The Business Research Company | PRODUCT CODE: 1951651
Consumer health contract manufacturing involves outsourcing the production of consumer health products, such as over-the-counter (OTC) medicines, dietary supplements, and personal care items, to specialized third-party manufacturers. This strategy allows brand owners to focus on key activities like marketing, distribution, and product development while leveraging the manufacturing expertise, regulatory compliance capabilities, and cost advantages of contract manufacturing partners.
The main product types in consumer health contract manufacturing include over-the-counter (OTC) drugs, nutritional supplements, personal care products, medical devices, and others. Over-the-counter (OTC) drugs are medications available without a prescription and are commonly used to treat everyday health issues such as pain, allergies, and cold symptoms. The services provided include active pharmaceutical ingredient (API) manufacturing, finished dosage manufacturing, medical device manufacturing, packaging and labeling, and other related services. These offerings serve a wide range of end users, including pharmaceutical and biopharmaceutical companies, nutraceutical companies, cosmeceutical companies, medical device companies, and others.
Tariffs have influenced the consumer health contract manufacturing market by increasing the cost of imported raw materials, active pharmaceutical ingredients (APIs), and packaging components. Segments like OTC drugs, nutritional supplements, and medical devices are particularly affected, with Asia-Pacific regions such as China and India experiencing higher import duties. This has resulted in elevated production costs and delayed timelines. On the positive side, tariffs have encouraged local sourcing, investment in domestic manufacturing capabilities, and innovation in cost-efficient production methods.
The consumer health contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides consumer health contract manufacturing market statistics, including consumer health contract manufacturing industry global market size, regional shares, competitors with a consumer health contract manufacturing market share, detailed consumer health contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the consumer health contract manufacturing industry. This consumer health contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The consumer health contract manufacturing market size has grown rapidly in recent years. It will grow from $155.62 billion in 2025 to $174.19 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to limited in-house manufacturing capabilities, rising demand for consumer health products, increasing focus on cost optimization, growing number of small and mid-size brands, lack of specialized manufacturing expertise.
The consumer health contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $270.3 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to expansion of contract manufacturing facilities, adoption of advanced automation and industry 4.0 technologies, rising consumer health awareness, increasing global outsourcing of personal care production, integration of digital supply chain management systems. Major trends in the forecast period include rising demand for outsourced otc drug manufacturing, growth in nutritional supplements and personal care contract services, increased focus on regulatory compliance and quality standards, expansion of packaging and labelling solutions, rising adoption of flexible manufacturing partnerships.
The increasing demand for consumer health products is anticipated to drive the growth of the consumer health contract manufacturing market in the coming years. Consumer health products include over-the-counter medications, dietary supplements, and personal care items that individuals use to manage their health and well-being without requiring a prescription. Demand for these products is rising as more consumers prioritize self-care and prefer convenient over-the-counter options to maintain health without frequent visits to healthcare providers. Consumer health contract manufacturing supports this trend by enabling companies to efficiently produce high-quality products through outsourcing to specialized manufacturers, allowing brand owners to concentrate on product innovation, marketing, and distribution. For instance, in September 2024, according to Barclays Bank UK PLC, a UK-based retail banking provider, data from July and August 2024 indicated strong performance in the health and beauty sector, with consumer spending increasing by 7.3% year-on-year in August 2024. Therefore, the rising demand for consumer health products is contributing to the growth of the consumer health contract manufacturing market.
Major companies operating in the consumer health contract manufacturing market are emphasizing the introduction of innovative solutions, such as contract development and manufacturing platforms, to optimize production workflows, improve scalability, and shorten time-to-market for consumer health products. A contract development and manufacturing platform is an integrated service model that combines product development activities, including formulation and testing, with large-scale manufacturing capabilities within a single framework. For instance, in October 2023, Lallemand Inc., a Canada-based company specializing in microorganism development, launched Expert Biome CDMO, a comprehensive contract development and manufacturing platform designed to support the development and production of next-generation probiotic and live biotherapeutic products. The platform delivers end-to-end services encompassing microbial strain research and development, bioprocess scale-up, drug manufacturing, formulation, and regulatory support. Operating under stringent quality standards such as cGMP Pharma, Expert Biome aims to address key challenges in the health supplements and live biotherapeutics markets.
In December 2024, Novo Holdings A/S, a Denmark-based investment firm, acquired Catalent Inc. for $16.5 billion. Through this acquisition, Novo Holdings seeks to reinforce Catalent's role as a leading global service provider to the pharmaceutical and biotechnology industries, supporting continued growth, innovation, and enhanced services for customers and patients worldwide, while advancing Novo Holdings' mission to invest for the benefit of people and the planet. Catalent Inc. is a US-based contract development and manufacturing organization (CDMO) that produces drug substances and finished dosage forms.
Major companies operating in the consumer health contract manufacturing market are Sirio Pharma Co. Ltd., Aenova Group, Vit-Best Nutrition Inc., Robinson Pharma Inc., Trividia Health Inc., Tishcon Corporation, SCN BestCo, Akums Drugs And Pharmaceuticals, Bactolac Pharmaceutical Inc., ION Labs Inc., Captek Softgel International.
North America was the largest region in the consumer health contract manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the consumer health contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the consumer health contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The consumer health contract manufacturing market consists of sales of products including herbal and botanical products, functional foods and beverages, probiotic formulations, topical health treatments, and vitamin-infused gummies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Consumer Health Contract Manufacturing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses consumer health contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for consumer health contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The consumer health contract manufacturing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.